Authors
Loading...
This research translates lung cancer biomarkers from nanoparticle-based LCMS to ELISA, indicating effective screening potential for patients.
Ho et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: